HMy2.CIR細(xì)胞系來源于HMy.2b淋巴母細(xì)胞系，是ARH-77細(xì)胞系（ATCC-CRL-1621）的快速生長突變體，通過γ射線照射和HLAⅠ類抗原表達(dá)缺失的選擇獲得，據(jù)報道，CRL-1621細(xì)胞系對Epstein-Barr核抗原（EBNA+）和Epstein-Barr病毒衣殼抗原（EBVCA+）呈陽性；由于HMy2.CIR細(xì)胞系來源于HMy.2b淋巴母細(xì)胞系，一種ARH-77細(xì)胞系（ATCC-CRL-1621）的快速生長突變體，它被認(rèn)為是EBNA陽性，細(xì)胞不表達(dá)HLA-A或B位點產(chǎn)物，但表達(dá)少量HLA-Cw4。

組織來源/Tissue and Cell Type ：外周血

形態(tài) ：淋巴母細(xì)胞樣  ，懸浮生長

培養(yǎng)基配方：

90%IMDM(MD0700)+10%胎牛血清(SD0200)+G/A (SD0038)

完全培養(yǎng)基：IMDM完全培養(yǎng)基（MD0701）

氣相：空氣，95%；二氧化碳，5%。 溫度：37℃。

凍存條件：基礎(chǔ)培養(yǎng)基+5%DMSO+20%FBS

完全凍存液：免程序降溫細(xì)胞凍存液（低血清）(SD0001)

聲明：產(chǎn)品僅科研使用。

PubMed=3819393

Storkus W.J., Howell D.N., Salter R.D., Dawson J.R., Cresswell P.

NK susceptibility varies inversely with target cell class I HLA antigen expression.

J. Immunol. 138:1657-1659(1987)

PubMed=2784569; DOI=10.1073/pnas.86.7.2361

Storkus W.J., Alexander J., Payne J.A., Dawson J.R., Cresswell P.

Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes.

Proc. Natl. Acad. Sci. U.S.A. 86:2361-2364(1989)

PubMed=1541831

Zemmour J., Little A.-M., Schendel D.J., Parham P.

The HLA-A,B 'negative' mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon.

J. Immunol. 148:1941-1948(1992)

PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001

Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R., Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K., Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D., Willis A., Askar M., Fischer G., Saw C.L., Ragoussis J., Petrek M., Serra-Pages C., Juan M., Stavropoulos-Giokas C., Dinou A., Ameen R., Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H., Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F., Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A., Fernandez-Vina M.A.

Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: report from the 17th International HLA and Immunogenetics Workshop.

Hum. Immunol. 80:449-460(2019)